Celldex Therapeutics reported $3.64M in Selling and Administration Expenses for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.23B 385M
Agenus AGEN:US $ 14.38M 185K
Amgen AMGN:US $ 1.77B 427M
Applied Genetic Technologies AGTC:US $ 2.94M 47K
Aptinyx Inc APTX:US $ 5.05M 280K
Arena Pharmaceuticals ARNA:US $ 34.9M 15.9M
Biocept BIOC:US $ 4.46M 1.21M
Bristol Myers Squibb BMY:US $ 2.72B 1.01B
Celldex Therapeutics CLDX:US $ 3.64M 112K
Glaxosmithkline GSK:US 2.92B 447M
Immunogen IMGN:US $ 9.74M 493K
Nektar Therapeutics NKTR:US $ 27.14M 154K
Newlink Genetics NLNK:US 5.16M 1.01M
Pfizer PFE:US $ 3.59B 716M
Rigel Pharmaceuticals RIGL:US $ 17.43M 1.49M
Seattle Genetics SGEN:US $ 158.36M 30.79M